SCHEMBL9114944

SCHEMBL9114944

CC1=Nc2ccccc2NC1=C=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.38
LMNA P02545 6/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
KDM4E B2RXH2 4/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 4/20 0.38
DRD2 P14416 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
DRD4 P21917 2/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
GAA P10253 5/20 0.37
POLB P06746 1/20 0.37
ALOX15 P16050 1/20 0.37
BRCA1 P38398 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306520 0.79 ALDH1A1 (0.38) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL4573048 0.75 LMNA (0.42) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL1773395 0.72 DRD2 (0.51) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL12355741 0.72 LMNA (0.40) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL1600165 0.66 ALDH1A1 (0.35) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL30133223 0.65 KMT2A (0.50) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL23721149 0.65 MAPT (0.36) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL7507906 0.64 ALDH1A1 (0.61) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL8718926 0.64 GAA (0.62) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL12208493 0.64 DRD2 (0.61) MAPTLMNAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed